Untech Inc

11:00 AM - 11:15 AM (PDT), Thursday, June 16, 2022 ・ Company Presentation Theater 4
Untech has created the cure for chronic wounds through a breakthrough biological medicament that includes all therapeutic requirements in a single product.

This all-in-one medication represents a low-cost treatment that:
1- Accelerates the healing time from years to months.
2- Drastically reduces the possibility of amputation.
3- Allows patients to remain ambulatory and apply the treatment themselves.

Untech has the Patent of this medicament granted in the USA and filed in 45 more countries, the Pre-clinical Phase is finished, and the Clinical Phase I is in progress in ANMAT (Argentinian FDA).
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Delaware
Company HQ Country:
United States
Year Founded:
2018
Main Therapeutic Focus:
Lead Product in Development:
Medicament for chronic wounds.
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1